LFCO Human Leukocyte DRB 3, 4, 5 Site Typing Reagent - Taiwan Registration 16d44fddc8489b336e556e8b7ad46960
Access comprehensive regulatory information for LFCO Human Leukocyte DRB 3, 4, 5 Site Typing Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 16d44fddc8489b336e556e8b7ad46960 and manufactured by IMMUCOR GTI DIAGNOSTICS, INC.. The authorized representative in Taiwan is METEK LAB INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
DNA typing of human leukocyte antigen dual genes DRB 3,4,5 is determined by sequence-specific oligonucleoacid fragment analysis (SSO), which is used with a Luminex instrument.
B Hematology, pathology, and genetics
B.0001 Human leukocyte antigen typing test system
import
Dates and Status
Apr 09, 2015
Apr 09, 2030